Chinese firm files $69M IPO

China Nuokang Bio-Pharmaceutical, a company focused on hematological and cardiovascular drugs, has filed an IPO and will offer 4.5 million American Depositary Shares on the Nasdaq exchange at a price between $10 and $12. In its SEC filing announcing the planned IPO, Nuokang points out that it will likely benefit from the healthcare reform proposal the Chinese government outlined earlier this...